Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter changes: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedVersion 3.3.2 on 2025-11-26 adds Contacts/Locations and updates Study Status for NCT04916470.SummaryDifference0.3%

- Check42 days agoChange DetectedFooter now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page no longer displays the government funding/operating status notice. This change does not affect the study record content, eligibility criteria, endpoints, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedA new version entry appears in the Record History, reflecting routine updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange Detected- Added a government funding lapse notice with operating status details and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference8%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.